Strata Oncology   Report issue

For profit Phase 1 Phase 2
Founded: Ann Arbor MI United States (2016)

Organization Overview

First Clinical Trial
2019
NCT04087018
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Strata Oncology

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 7